1. Home
  2. FLOC vs PHAT Comparison

FLOC vs PHAT Comparison

Compare FLOC & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flowco Holdings Inc.

FLOC

Flowco Holdings Inc.

HOLD

Current Price

$18.48

Market Cap

806.0M

Sector

Industrials

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$7.31

Market Cap

676.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLOC
PHAT
Founded
1996
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
806.0M
676.3M
IPO Year
2024
2019

Fundamental Metrics

Financial Performance
Metric
FLOC
PHAT
Price
$18.48
$7.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
★ $28.50
$19.83
AVG Volume (30 Days)
490.5K
★ 1.1M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
★ 1.31%
N/A
EPS Growth
N/A
★ 42.72
EPS
★ 0.52
N/A
Revenue
★ $759,719,000.00
$175,110,000.00
Revenue This Year
$22.92
$93.04
Revenue Next Year
$8.59
$58.91
P/E Ratio
$36.50
★ N/A
Revenue Growth
41.93
★ 216.93
52 Week Low
$14.03
$6.91
52 Week High
$28.26
$18.31

Technical Indicators

Market Signals
Indicator
FLOC
PHAT
Relative Strength Index (RSI) 32.63 36.45
Support Level $17.60 N/A
Resistance Level $24.32 $9.74
Average True Range (ATR) 0.84 0.40
MACD -0.16 -0.05
Stochastic Oscillator 2.61 20.57

Price Performance

Historical Comparison
FLOC
PHAT

About FLOC Flowco Holdings Inc.

Flowco Holdings Inc is a provider of production optimization, artificial lift, emissions management, and monetization solutions for the oil and natural gas industry. Its technologies include high-pressure gas lift (HPGL), conventional gas lift, plunger lift, and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions, which includes rental services, and Natural Gas Technologies, which include service, gas compression parts, and equipment sales. Production Solutions: relates to rentals, sales, and services related to high-pressure gas lift, conventional gas lift, and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue. It generates maximum revenue from the United States.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: